NCT06263907 Stellate Ganglion Block for Prevention of Post Mastectomy Depression
| NCT ID | NCT06263907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University |
| Condition | Mastectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2024-03-01 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Complications after mastectomy include chronic pain and depression.
Eligibility Criteria
Inclusion Criteria: * Female patients * Age ranging from 18 to 65 years * American Society of Anesthesiologists (ASA) no more than II * Had unilateral cancer breast * Scheduled to do unilateral modified radical mastectomy Exclusion Criteria: * Pregnant female * Existing Horner syndrome * Had any neuromuscular disease * Had allergy to local anesthetics * History of use of analgesics * Had any deformity or a previous surgery in the neck or ipsilateral arm or breast * Had any contraindication to the procedure (coagulation disorders, local infection, sepsis) * Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary or hemodynamic disorders) * History of psychotic disorder including depression, bipolar disorder or personality disorder * Patient with Beck Depression Inventory (BDI) score more than 13
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06263907 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 65 Years, studying Mastectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06263907 currently recruiting?
Yes, NCT06263907 is actively recruiting participants. Contact the research team at mahazed@mans.edu.eg for enrollment information.
Where is the NCT06263907 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT06263907 clinical trial?
NCT06263907 is sponsored by Mansoura University. The trial plans to enroll 140 participants.